AMGN Amgen Inc. Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg's Top 50 ✓
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
17:47
Jun 03
Victoria Fernandez Representative, Crossmark Global Investments Bloomberg Markets
Healthcare AI adoption benefits AbbVie, Amgen.
Healthcare and biotech companies using AI to improve drug discovery and medical field will see significant gains. Specifically, AbbVie and Amgen are already held in her portfolio and present attractive opportunities as AI adoption accelerates in the sector.
AMGN 1ST
MED
12:56
May 08
A May MD Biotech investor
Adam May argues Nektar Therapeutics' bold Phase 3 strategy for Rezpeg in atopic dermatitis, including a biologic-refractory trial no pharma giant has run, could drive over $5B in peak sales and make NKTR a glaring M&A candidate at current prices.
AMGN
HIGH
00:04
Apr 26
TraderStewie Founder, Art of Trading
Traderstewie shares a list of upcoming earnings from Earnings Whispers for the week of April 27, 2026, but
AMGN
HIGH

About AMGN Analyst Coverage

Buzzberg tracks AMGN (Amgen Inc.) across 3 sources. 1 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (33%). 3 total trade ideas tracked.